Emmanuelle Charpentier#910
$128.89▼ 18.72% 1W
Emmanuelle Charpentier
Science$AURA: 128.89
▼18.72%1W
Rank #910
Crowd: +0.0%
A scientist, Emmanuelle Charpentier is known for co-developing the CRISPR-Cas9 gene-editing technology.
Rank
#910
by $AURA
Price History
AURA News
Hover to see on chartEvents that have affected this price
Nobel Prize winners face new loss in bid for US CRISPR patents
Reuters2w ago
→
French microbiologist Emmanuelle Charpentier (L) and professor Jennifer Doudna of the U.S. pose for the media during a visit to a painting exhibition by children about the genome, at the San Francisco park in Oviedo
Reuters Connect2w ago
→
PTAB sides with Broad Institute over University of California on patent priority for use of CRISPR in eukaryotic cells
University of California, Berkeley2w ago
→
Therapeutic targeting for SARS-CoV-2 using CRISPR-Cas13
Doherty Institute3w ago
→
The revolutionary CRISPR-Cas9 gene editing tool
Umeå universitet3w ago
→
Emmanuelle Charpentier
Britannica4w ago
→
Statistics
24h Change-2.47%
1W Change-19.17%
Market Cap128.9M $AURA
All-Time High$AURA 427.13
All-Time Low$AURA 120.50
Crowd Sentiment+0.0%
Crowd Activity
Neutral, no crowd pressure
SellersNeutralBuyers
AURA traded (24h)+0 AURA
You might also like
More in Science
Reid Wiseman
#1
753.04
▲ +2.20%
Jeremy Hansen
#2
745.29
▲ +2.31%
Christina Koch
#7
638.12
▲ +7.86%
David Attenborough
#34
547.64
▼ -6.23%
Chris Hadfield
#104
428.95
▲ +6.79%
Brian Cox
#117
407.47
▼ -3.24%
Katalin Karikó
#220
333.96
▼ -9.18%
Victor Glover
#302
294.58
▼ -4.77%
Neil deGrasse Tyson
#326
287.04
▼ -10.72%
Jane Goodall
#332
285.53
▲ +29.99%
Hannah Fry
#386
267.74
▼ -1.33%
Terence Tao
#465
253.85
▲ +25.26%